|Articles|July 1, 2020 (Updated: November 15, 2020)
- Pharmaceutical Executive-07-01-2020
- Volume 40
- Issue 7
Pharmaceutical Executive, July 2020 Issue (PDF)
Click the title above to open the Pharmaceutical Executive July 2020 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 5 years ago
Will COVID-19 Usher in a New Era in Pharma Marketing?over 5 years ago
Is Drug Production Heading Back to Europe From Abroad?over 5 years ago
Central Focus: Targeting Unmet Need in CNSover 5 years ago
Will the Industry Rise to the Occasion?over 5 years ago
How Oncologists are Coping with COVID-19over 5 years ago
Virtual Hiring of the C-Suiteover 5 years ago
Culture and Compliance: Building a Culture of Business Ethicsover 5 years ago
Fauci: Industry Will ‘Walk Away’ From COVID Price Controlsover 5 years ago
A Sustainable Response to COVID-19over 5 years ago
Enterprise Leadership: Is Compliance Ripe for Disruption?Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Leading in the Psychedelic Space: Q&A with Tarek Rabah
3
Boehringer Ingelheim Acquires Exclusive License from Sitryx Therapeutics for Preclinical Small Molecule Program
4
Pharma Leadership Roundup: Sarepta Therapeutics CEO Announces Retirement, Rivus Pharmaceuticals Appoints New CEO
5
